Latest news
25 items- 13D/GSEC Form SC 13G/A filed by Medicus Sciences Acquisition Corp. (Amendment)SC 13G/A - Medicus Sciences Acquisition Corp. (0001836517) (Subject)
- 13D/GSEC Form SC 13G/A filed by Medicus Sciences Acquisition Corp. (Amendment)SC 13G/A - Medicus Sciences Acquisition Corp. (0001836517) (Subject)
- SECSEC Form 15-12G filed by Medicus Sciences Acquisition Corp.15-12G - Medicus Sciences Acquisition Corp. (0001836517) (Filer)
- SECSEC Form 25-NSE filed by Medicus Sciences Acquisition Corp.25-NSE - Medicus Sciences Acquisition Corp. (0001836517) (Subject)
- 13D/GSEC Form SC 13G/A filed by Medicus Sciences Acquisition Corp. (Amendment)SC 13G/A - Medicus Sciences Acquisition Corp. (0001836517) (Subject)
- 13D/GSEC Form SC 13G filed by Medicus Sciences Acquisition Corp.SC 13G - Medicus Sciences Acquisition Corp. (0001836517) (Subject)
- 13D/GSEC Form SC 13G filed by Medicus Sciences Acquisition Corp.SC 13G - Medicus Sciences Acquisition Corp. (0001836517) (Subject)
- SECMedicus Sciences Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Medicus Sciences Acquisition Corp. (0001836517) (Filer)
- NEWSMedicus Sciences Acquisition Corp. Announces LiquidationMedicus Sciences Acquisition Corp. (the "Company") (NASDAQ:MSAC), announced today that due to its inability to consummate an initial business combination within the time period required by its amended and restated memorandum and articles of association (the "Charter"), the Board of Directors of the Company has elected to dissolve and liquidate the Company in accordance with the provisions of its Charter, and will redeem all of the outstanding Class A ordinary shares that were included in the units issued in its initial public offering (the "Public Shares"), at a per-share redemption price of approximately $10.18.
- PRMedicus Sciences Acquisition Corp. Announces LiquidationNEW YORK, Feb. 13, 2023 /PRNewswire/ -- Medicus Sciences Acquisition Corp. (the "Company") (NASDAQ:MSAC), announced today that due to its inability to consummate an initial business combination within the time period required by its amended and restated memorandum and articles of association (the "Charter"), the Board of Directors of the Company has elected to dissolve and liquidate the Company in accordance with the provisions of its Charter, and will redeem all of the outstanding Class A ordinary shares that were included in the units issued in its initial public offering (the "Public Shares"), at a per-share redemption price of approximately $10.18. As of the close of business on Februar
- 13D/GSEC Form SC 13G/A filed by Medicus Sciences Acquisition Corp. (Amendment)SC 13G/A - Medicus Sciences Acquisition Corp. (0001836517) (Subject)
- 13D/GSEC Form SC 13G/A filed by Medicus Sciences Acquisition Corp. (Amendment)SC 13G/A - Medicus Sciences Acquisition Corp. (0001836517) (Subject)
- SECMedicus Sciences Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Medicus Sciences Acquisition Corp. (0001836517) (Filer)
- SECSEC Form 10-Q filed by Medicus Sciences Acquisition Corp.10-Q - Medicus Sciences Acquisition Corp. (0001836517) (Filer)
- SECSEC Form 10-Q filed by Medicus Sciences Acquisition Corp.10-Q - Medicus Sciences Acquisition Corp. (0001836517) (Filer)
- SECSEC Form 10-Q filed by Medicus Sciences Acquisition Corp.10-Q - Medicus Sciences Acquisition Corp. (0001836517) (Filer)
- SECMedicus Sciences Acquisition Corp. filed SEC Form 8-K: Leadership Update8-K - Medicus Sciences Acquisition Corp. (0001836517) (Filer)
- 13D/GSEC Form SC 13G filed by Medicus Sciences Acquisition Corp.SC 13G - Medicus Sciences Acquisition Corp. (0001836517) (Subject)
- NEWSMedicus Sciences Acquisition Says Discussions Between Co, Anteris Regarding Possible Transactions Have Ceased-SEC Filing
- SECMedicus Sciences Acquisition Corp. filed SEC Form 8-K: Regulation FD Disclosure8-K - Medicus Sciences Acquisition Corp. (0001836517) (Filer)
- 13D/GSEC Form SC 13G filed by Medicus Sciences Acquisition Corp.SC 13G - Medicus Sciences Acquisition Corp. (0001836517) (Subject)
- 13D/GSEC Form SC 13G/A filed by Medicus Sciences Acquisition Corp. (Amendment)SC 13G/A - Medicus Sciences Acquisition Corp. (0001836517) (Subject)
- 13D/GSEC Form SC 13G/A filed by Medicus Sciences Acquisition Corp. (Amendment)SC 13G/A - Medicus Sciences Acquisition Corp. (0001836517) (Subject)
- SECMedicus Sciences Acquisition Corp. filed SEC Form 8-K: Regulation FD Disclosure8-K - Medicus Sciences Acquisition Corp. (0001836517) (Filer)
- SECSEC Form 10-Q/A filed by Medicus Sciences Acquisition Corp. (Amendment)10-Q/A - Medicus Sciences Acquisition Corp. (0001836517) (Filer)
MSAC FAQ
6 questionsWhat does Medicus Sciences Acquisition Corp. do?
Medicus Sciences Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on the healthcare industry primarily the medical technology sector in the United States and internationally. The company was incorporated in 2020 and is based in New York, New York.Where does MSAC stock trade?
Medicus Sciences Acquisition Corp. (MSAC) is listed on NASDAQ.What sector and industry is MSAC in?
Medicus Sciences Acquisition Corp. operates in the Finance sector, Blank Checks industry.When did Medicus Sciences Acquisition Corp. go public?
Medicus Sciences Acquisition Corp. (MSAC) completed its IPO in 2021.What companies are similar to MSAC?
Notable peers in the same industry include CVII (Churchill Capital Corp VII), JWSM (Jaws Mustang Acquisition Corp.), HERA (FTAC Hera Acquisition Corp.), CPUH (Compute Health Acquisition Corp.), CONX (CONX Corp.). Compare MSAC side-by-side with any of them on Quantisnow.How can I track MSAC on Quantisnow?
Quantisnow aggregates Medicus Sciences Acquisition Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MSAC to receive live email and push alerts on every new disclosure.